Loading clinical trials...

Efficacy of Roflumilast in the Treatment of Psoriasis | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT04549870

Efficacy of Roflumilast in the Treatment of Psoriasis

Roflumilast (Daxas®), a selective, long-acting inhibitor of the enzyme phosphodiesterase-4 (PDE4), is used for severe chronic obstructive pulmonary disease. Recent research suggest roflumilast is effe...

Lead sponsor: Bispebjerg Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

A Study of Persistence to Guselkumab Treatment in Participants With Moderate-to-Severe Plaque Psoriasis in Romania

NCT07582783 · Psoriasis

RECRUITINGPhase 2

Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis

NCT07290569 · Plaque Psoriasis

RECRUITINGPhase 1

Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease

NCT07455578 · Autoimmune Diseases, Rheumatoid Arthritis (RA), and more

RECRUITINGPhase 3

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis

NCT06425549 · Moderate to Severe Plaque Psoriasis

RECRUITINGPhase 2

Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis

NCT07474792 · Plaque Psoriasis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 28, 2023Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment46

Start dateJan 2021

Last updatedJun 28, 2023

Condition

Psoriasis

Locations shown

Bispebjerg Hospital

Copenhagen

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 28, 2023Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions